The anti-apoptotic potential of the transfected AKT constructs (WT and phosphomimetic versions) is shown by their ability to inhibit MM cell apoptosis induced by bortezomib (fig 3G). The gene discussed is AKT1; the disease is Miyoshi myopathy.